Sonelokimab Yields Significant Improvements in Active PsA

Patients receiving sonelokimab experienced higher treatment response in ACR20, ACR50, and PASI90 than those in the placebo group.
Medscape Medical News

source https://www.medscape.com/viewarticle/sonelokimab-yields-significant-improvements-active-psa-early-2024a1000buo?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?